Seth Harmon
Chief Financial Officer · 3 filings · Latest: Mar 3, 2026
Viridian Therapeutics, Inc.\DE
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
VRDN | Seth Harmon | Chief Financial Officer | Mar 3, 2026 | Option Exercise | — | 6,267 | — | 9,881 | |
VRDN | Harmon Seth | — | Mar 4, 2026 | Proposed Sale | $30.19 | 2,031 | $61.3K | — | |